Cargando…
New Tetrahydroacridine Hybrids with Dichlorobenzoic Acid Moiety Demonstrating Multifunctional Potential for the Treatment of Alzheimer’s Disease
A series of new tetrahydroacridine and 3,5-dichlorobenzoic acid hybrids with different spacers were designed, synthesized, and evaluated for their ability to inhibit both cholinesterase enzymes. Compounds 3a, 3b, 3f, and 3g exhibited selective butyrylcholinesterase (EqBuChE) inhibition with IC(50) v...
Autores principales: | Czarnecka, Kamila, Girek, Małgorzata, Wójtowicz, Przemysław, Kręcisz, Paweł, Skibiński, Robert, Jończyk, Jakub, Łątka, Kamil, Bajda, Marek, Walczak, Anna, Galita, Grzegorz, Kabziński, Jacek, Majsterek, Ireneusz, Szymczyk, Piotr, Szymański, Paweł |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312527/ https://www.ncbi.nlm.nih.gov/pubmed/32466601 http://dx.doi.org/10.3390/ijms21113765 |
Ejemplares similares
-
New cyclopentaquinoline and 3,5-dichlorobenzoic acid hybrids with neuroprotection against oxidative stress for the treatment of Alzheimer’s disease
por: Czarnecka, Kamila, et al.
Publicado: (2023) -
Discovery of New Cyclopentaquinoline Analogues as Multifunctional Agents for the Treatment of Alzheimer’s Disease
por: Czarnecka, Kamila, et al.
Publicado: (2019) -
New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer’s disease
por: Czarnecka, Kamila, et al.
Publicado: (2017) -
Biological assessment of new tetrahydroacridine derivatives with fluorobenzoic moiety in vitro on A549 and HT-29 cell lines and in vivo on animal model
por: Kłosiński, Karol, et al.
Publicado: (2020) -
Novel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cells
por: Girek, Małgorzata, et al.
Publicado: (2019)